(Q38243119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Oral delivery of nanoparticle-based vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Mariusz Skwarczynski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Istvan Toth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Nirmal Marasini

1

1 reference

31 August 2017

Mariusz Skwarczynski

2

1 reference

31 August 2017

Istvan Toth

3

1 reference

31 August 2017

26 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1361-1376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155636%20AND%20SRC:MED&resulttype=core&format=json

Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The immune geography of IgA induction and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Recent progress in mucosal vaccine development: potential and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

New insights in mucosal vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Oral tolerance to food protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Gut-associated lymphoid tissues for the development of oral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Targeted nanoparticles with novel non-peptidic ligands for oral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The role of the lymphatic system in vaccine trafficking and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Antigen sampling in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Enhancing oral vaccine potency by targeting intestinal M cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Designing oral vaccines targeting intestinal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Mucosal dendritic cells shape mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Oral vaccine delivery--new strategies and technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Peptide-based subunit nanovaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Liposomes as nanovaccine delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Liposome-based delivery system for vaccine candidates: constructing an effective formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Archaeosome adjuvants: immunological capabilities and mechanism(s) of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Archaeosomes with encapsulated antigens for oral vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

The history of MF59(®) adjuvant: a phoenix that arose from the ashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Advances in saponin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

21 January 2018

ISCOMs and ISCOMATRIX.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Working together: interactions between vaccine antigens and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Lipid based particulate formulations for the delivery of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Construction and characterization of virus-like particles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Virus-like particles as particulate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Chimeric hepatitis E virus-like particle as a carrier for oral-delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Encapsulation and delivery of plasmid DNA by virus-like nanoparticles engineered from Macrobrachium rosenbergii nodavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Applications of nanotechnology for immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Chitosan-based delivery systems for mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Accelerated immune response to DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Use of animal models in the development of human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Poly(acrylic acid)-stabilized colloidal gold nanoparticles: synthesis and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.936852